Activation and Allosteric Modulation of Human μ Opioid Receptor in Molecular Dynamics

Journal of Chemical Information and Modeling

Volumn 55, Issue 11, 2015, Pages 2421-2434

  Bartuzi, Damian ^a   Kaczor, Agnieszka A ^a,b   Matosiuk, Dariusz ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

LIGANDS; MODULATION; MODULATORS;

ALLOSTERIC MODULATION; ALLOSTERIC MODULATORS; ALLOSTERIC PROTEINS; HOMOLOGY MODELING; IMMUNE DISORDERS; MECHANISM OF ACTION; MOLECULAR DYNAMICS SIMULATIONS; OPIOID RECEPTORS;

MOLECULAR DYNAMICS;

9-(BENZOYLOXY)-2-(3-FURANYL)DODECAHYDRO-6A,10B-DIMETHYL-4,10-DIOXO-2H-NAPHTHO(2,1-C)PYRAN-7-CARBOXYLIC ACID METHYL ESTER; CLERODANE DERIVATIVE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; FURAN DERIVATIVE; LIGAND; MORPHINE; MU OPIATE RECEPTOR; PYRONE DERIVATIVE; SALVINORIN A;

AGONISTS; ALLOSTERISM; BINDING SITE; CHEMISTRY; DRUG EFFECTS; HUMAN; METABOLISM; MOLECULAR DOCKING; MOLECULAR DYNAMICS; SALVIA;

ALLOSTERIC REGULATION; ALLOSTERIC SITE; DITERPENES, CLERODANE; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; FURANS; HUMANS; LIGANDS; MOLECULAR DOCKING SIMULATION; MOLECULAR DYNAMICS SIMULATION; MORPHINE; PYRONES; RECEPTORS, OPIOID, MU; SALVIA;

EID: 84947998906     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/acs.jcim.5b00280     Document Type: Article

References (75)

1. Luttrell, L. M. Minireview: More Than Just a Hammer: Ligand "Bias"? and Pharmaceutical Discovery Mol. Endocrinol. 2014, 28, 281-294 10.1210/me.2013-1314
2. Lane, J. R.; Donthamsetti, P.; Shonberg, J.; Draper-Joyce, C. J.; Dentry, S.; Michino, M.; Shi, L.; López, L.; Scammells, P. J.; Capuano, B.; Sexton, P. M.; Javitch, J. A.; Christopoulos, A. A New Mechanism of Allostery in a G protein-coupled Receptor Dimer Nat. Chem. Biol. 2014, 10, 745-752 10.1038/nchembio.1593
3. Ghanemi, A. Targeting G protein coupled receptor-related pathways as emerging molecular therapies Saudi Pharm. J. 2015, 23, 115-129 10.1016/j.jsps.2013.07.007
4. Drews, J. Drug Discovery: a Historical Perspective Science 2000, 287, 1960-1964 10.1126/science.287.5460.1960
5. Fredriksson, R.; Lagerström, M. C.; Lundin, L. G.; Schiöth, H. B. The G-protein-coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints Mol. Pharmacol. 2003, 63, 1256-72 10.1124/mol.63.6.1256
6. Kolakowski, L. F., Jr. GCRDb: a G-protein-coupled Receptor Database Recept. Channels 1994, 2, 1-7
7. Pelé, J.; Abdi, H.; Moreau, M.; Thybert, D.; Chabbert, M. Multidimensional Scaling Reveals the Main Evolutionary Pathways of Class A G-protein-coupled Receptors PLoS One 2011, 6, e19094 10.1371/journal.pone.0019094
8. Yuan, S.; Vogel, H.; Filipek, S. The Role of Water and Sodium Ions in the Activation of the m-Opioid Receptor Angew. Chem., Int. Ed. 2013, 52, 10112-10115 10.1002/anie.201302244
9. Shang, Y.; LeRouzic, V.; Schneider, S.; Bisignano, P.; Pasternak, G. W.; Filizola, M. Mechanistic Insights into the Allosteric Modulation of Opioid Receptors by Sodium Ions Biochemistry 2014, 53, 5140-5149 10.1021/bi5006915
10. Yuan, S.; Filipek, S.; Palczewski, K.; Vogel, H. Activation of G-protein-coupled Receptors Correlates with the Formation of a Continuous Internal Water Pathway Nat. Commun. 2014, 5, 4733 10.1038/ncomms5733
11. Dror, R. O.; Green, H. F.; Valant, C.; Borhani, D. W.; Valcourt, J. R.; Pan, A. C.; Arlow, D. H.; Canals, M.; Lane, J. R.; Rahmani, R.; Baell, J. B.; Sexton, P. M.; Christopoulos, A.; Shaw, D. E. Structural Basis for Modulation of a G-protein-coupled Receptor by Allosteric Drugs Nature 2013, 503, 295-299 10.1038/nature12595
12. Abdul-Ridha, A.; López, L.; Keov, P.; Thal, D. M.; Mistry, S. N.; Sexton, P. M.; Lane, J. R.; Canals, M.; Christopoulos, A. Molecular Determinants of Allosteric Modulation at the M1 Muscarinic Acetylcholine Receptor J. Biol. Chem. 2014, 289, 6067-6079 10.1074/jbc.M113.539080
13. Manglik, A.; Kruse, A. C.; Kobilka, T. S.; Thian, F. S.; Mathiesen, J. M.; Sunahara, R. K.; Pardo, L.; Weis, W. I.; Kobilka, B. K.; Granier, S. Crystal Structure of the M-opioid Receptor Bound to a Morphinan Antagonist Nature 2012, 485, 321-326 10.1038/nature10954
14. Shim, J.; Coop, A.; MacKerell, A. D., Jr. Molecular Details of the Activation of the μ Opioid Receptor J. Phys. Chem. B 2013, 117, 7907-7917 10.1021/jp404238n
15. Provasi, D.; Artacho, M. C.; Negri, A.; Mobarec, J. C.; Filizola, M. Ligand-Induced Modulation of the Free-Energy Landscape of G Protein-Coupled Receptors Explored by Adaptive Biasing Techniques PLoS Comput. Biol. 2011, 7, e1002193 10.1371/journal.pcbi.1002193
16. Kathmann, M.; Flau, K.; Redmer, A.; Tränkle, C.; Schlicker, E. Cannabidiol is an Allosteric Modulator at Mu- and Delta-opioid Receptors Naunyn-Schmiedeberg's Arch. Pharmacol. 2006, 372, 354-361 10.1007/s00210-006-0033-x
17. Rothman, R. B.; Murphy, D. L.; Xu, H.; Godin, J. A.; Dersch, C. M.; Partilla, J. S.; Tidgewell, K.; Schmidt, M.; Prisinzano, T. E. Salvinorin A: Allosteric Interactions at the m-Opioid Receptor J. Pharmacol. Exp. Ther. 2007, 320, 801-810 10.1124/jpet.106.113167
18. Burford, N. T.; Clark, M. J.; Wehrman, T. S.; Gerritz, S. W.; Banks, M.; O'Connell, J.; Traynor, J. R.; Alt, A. Discovery of Positive Allosteric Modulators and Silent Allosteric Modulators of the μ-opioid Receptor Proc. Natl. Acad. Sci. U. S. A. 2013, 110, 10830-10835 10.1073/pnas.1300393110
19. Balsera, M. A.; Wriggers, W.; Oono, Y.; Schulten, K. Principal Component Analysis and Long Time Protein Dynamics J. Phys. Chem. 1996, 100, 2567-2572 10.1021/jp9536920
20. Ng, H. W.; Laughton, C. A.; Doughty, S. W. Molecular Dynamics Simulations of the Adenosine A2a Receptor in POPC and POPE Lipid Bilayers: Effects of Membrane on Protein Behavior J. Chem. Inf. Model. 2014, 54, 573-81 10.1021/ci400463z
21. Ng, H. W.; Laughton, C. A.; Doughty, S. W. Molecular Dynamics Simulations of the Adenosine A2a Receptor: Structural Stability, Sampling, and Convergence J. Chem. Inf. Model. 2013, 53, 1168-78 10.1021/ci300610w
22. Kaczor, A. A.; Bartuzi, D.; Matosiuk, D. Modeling the Active Conformation of Human μ Opioid Receptor Lett. Drug Des. Discovery 2014, 11, 1053-1061 10.2174/1570180811666140322001506
23. Katoh, K.; Standley, D. M. MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability Mol. Biol. Evol. 2013, 30, 772-780 10.1093/molbev/mst010
24. Warne, A.; Moukhametzianov, R.; Baker, J. G.; Nehme, R.; Edwards, P. C.; Leslie, A. G. W.; Schertler, G. F. X.; Tate, C. G. The Structural Basis for Agonist and Partial Agonist Action on a β1-adrenergic Receptor Nature 2011, 469, 241-244 10.1038/nature09746
25. Rasmussen, S. G.; Choi, H. J.; Fung, J. J.; Pardon, E.; Casarosa, P.; Chae, P. S.; Devree, B. T.; Rosenbaum, D. M.; Thian, F. S.; Kobilka, T. S.; Schnapp, A.; Konetzki, I.; Sunahara, R. K.; Gellman, S. H.; Pautsch, A.; Steyaert, J.; Weis, W. I.; Kobilka, B. K. Structure of a Nanobody-stabilized Active State of the b(2) Adrenoceptor Nature 2011, 469, 175-180 10.1038/nature09648
26. Rosenbaum, D. M.; Zhang, C.; Lyons, J. A.; Holl, R.; Aragao, D.; Arlow, D. H.; Rasmussen, S. G. F.; Choi, H. J.; Devree, B. T.; Sunahara, R. K.; Chae, P. S.; Gellman, S. H.; Dror, R. O.; Shaw, D. E.; Weis, W. I.; Caffrey, M.; Gmeiner, P.; Kobilka, B. K. Structure and Function of an Irreversible Agonist-b2 Adrenoceptor complex Nature 2011, 469, 236-240 10.1038/nature09665
27. Rasmussen, S. G.; DeVree, B. T.; Zou, Y.; Kruse, A. C.; Chung, K. Y.; Kobilka, T. S.; Thian, F. S.; Chae, P. S.; Pardon, E.; Calinski, D.; Mathiesen, J. M.; Shah, S. T.; Lyons, J. A.; Caffrey, M.; Gellman, S. H.; Steyaert, J.; Skiniotis, G.; Weis, W. I.; Sunahara, R. K.; Kobilka, B. K. Crystal Structure of the b2 Adrenergic Receptor-Gs protein Complex Nature 2011, 477, 549-555 10.1038/nature10361
28. Lebon, G.; Warne, T.; Edwards, P. C.; Bennett, K.; Langmead, C. J.; Leslie, A. G. W.; Tate, C. G. Agonist-bound Adenosine A2A Receptor Structures Reveal Common Features of GPCR Activation Nature 2011, 474, 521-525 10.1038/nature10136
29. Xu, F.; Wu, H.; Katritch, V.; Han, G. W.; Jacobson, K. A.; Gao, Z. G.; Cherezov, V.; Stevens, R. C. Structure of an Agonist-bound Human A2A Adenosine Receptor Science 2011, 332, 322-327 10.1126/science.1202793
30. Eswar, N.; Marti-Renom, M. A.; Webb, B.; Madhusudhan, M. S.; Eramian, D.; Shen, M.; Pieper, U.; Sali, A. Comparative Protein Structure Modeling With MODELLER. In Current Protocols in Bioinformatics; John Wiley & Sons, Inc., 2006; Supplement 15, pp 5.6.1-5.6.30.
31. Chakrabarti, S.; Chang, A.; Gintzler, A. R. Subcellular Localization of Mu-opioid Receptor G(s) Signaling J. Pharmacol. Exp. Ther. 2010, 333, 193-200 10.1124/jpet.109.165142
32. Allen, F. H. The Cambridge Structural Database: a Quarter of a Million Crystal Structures and Rising Acta Crystallogr., Sect. B: Struct. Sci. 2002, B58, 380-388 10.1107/S0108768102003890
33. Spartan'10; Wavefunction, Inc.: Irvine, CA, 2010; https://www.wavefun.com/products/windows/Spartan10/win
34. SYBYL-X 1.3; Tripos International: St. Louis, MO, 2009.
35. Pike, L. J.; Han, X.; Chung, K.-N.; Gross, R. W. Lipid Rafts Are Enriched in Arachidonic Acid and Plasmenylethanolamine and Their Composition Is Independent of Caveolin-1 Expression: A Quantitative Electrospray Ionization/Mass Spectro metric Analysis Biochemistry 2002, 41, 2075-2088 10.1021/bi0156557
36. Case, D. A.; Babin, V.; Berryman, J. T.; Betz, R. M.; Cai, Q.; Cerutti, D. S.; Cheatham, T. E.; Darden, T. A.; Duke, R. E.; Gohlke, H.; Goetz, A. W.; Gusarov, S.; Homeyer, N.; Janowski, P.; Kaus, J.; Kolossváry, I.; Kovalenko, A.; Lee, T. S.; LeGrand, S.; Luchko, T.; Luo, R.; Madej, B.; Merz, K. M.; Paesani, F.; Roe, D. R.; Roitberg, A.; Sagui, C.; Salomon-Ferrer, R.; Seabra, G.; Simmerling, C. L.; Smith, W.; Swails, J.; Walker, R. C.; Wang, J.; Wolf, R. M.; Wu, X.; Kollman, P. A. AMBER 14; University of California: San Francisco, 2014.
37. Wang, J.; Wang, W.; Kollman, P. A.; Case, D. A. Automatic Atom Type and Bond Type Perception in Molecular Mechanical Calculations J. Mol. Graphics Modell. 2006, 25, 247-260 10.1016/j.jmgm.2005.12.005
38. Wang, J.; Wolf, R. M.; Caldwell, J. W.; Kollman, P. A.; Case, D. A. Development and Testing of a General AMBER Force Field J. Comput. Chem. 2004, 25, 1157-1174 10.1002/jcc.20035
39. Jämbeck, J. P. M.; Lyubartsev, A. P. Derivation and Systematic Validation of a Refined All-Atom Force Field for Phosphatidylcholine Lipids J. Phys. Chem. B 2012, 116, 3164-3179 10.1021/jp212503e
40. Jämbeck, J. P. M.; Lyubartsev, A. P. An Extension and Further Validation of an All-Atomistic Force Field for Biological Membranes J. Chem. Theory Comput. 2012, 8, 2938-2948 10.1021/ct300342n
41. Jämbeck, J. P. M.; Lyubartsev, A. P. Another Piece of the Membrane Puzzle: Extending Slipids Further J. Chem. Theory Comput. 2013, 9, 774-784 10.1021/ct300777p
42. Vanquelef, E.; Simon, S.; Marquant, G.; Garcia, E.; Klimerak, G.; Delepine, J. C.; Cieplak, P.; Dupradeau, F.Y. R.E.D. Server: a Web Service for Deriving RESP and ESP Charges and Building Force Field Libraries for New Molecules and Molecular Fragments Nucleic Acids Res. 2011, 39, W511-W517 10.1093/nar/gkr288
43. Sousa da Silva, A. W.; Vranken, W. F. ACPYPE-AnteChamber PYthon Parser interfacE BMC Res. Notes 2012, 5, 367 10.1186/1756-0500-5-367
44. Wu, E. L.; Cheng, X.; Jo, S.; Rui, H.; Song, K. C.; Dávila-Contreras, E. M.; Qi, Y.; Lee, J.; Monje-Galvan, V.; Venable, R. M.; Klauda, J. B.; Im, W. CHARMM-GUI Membrane Builder Toward Realistic Biological Membrane Simulations J. Comput. Chem. 2014, 35, 1997-2004 10.1002/jcc.23702
45. Hess, B.; Kutzner, C.; van der Spoel, D.; Lindahl, E. GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation J. Chem. Theory Comput. 2008, 4, 435-447 10.1021/ct700301q
46. R: A Language and Environment for Statistical Computing; R Foundation for Statistical Computing: Vienna, Austria, 2014; http://www.R-project.org.
47. Humphrey, W.; Dalke, A.; Schulten, K. VMD-Visual Molecular Dynamics J. Mol. Graphics 1996, 14.1, 33-38 http://www.ks.uiuc.edu/Research/vmd/ 10.1016/0263-7855(96)00018-5
48. The PyMOL Molecular Graphics System, Version 1.5.0.4; Schrödinger, LLC, 2012.
49. Kane, B. E.; McCurdy, C. R.; Ferguson, D. M. Toward a Structure-based Model of Salvinorin A Recognition of the Kappa-opioid Receptor J. Med. Chem. 2008, 51, 1824-30 10.1021/jm701040v
50. Ballesteros, J. A.; Weinstein, H. Integrated Methods for the Construction of Three Dimensional Models and Computational Probing of Structure-Function Relations in G-protein Coupled Receptors Methods Neurosci. 1995, 25, 366-428 10.1016/S1043-9471(05)80049-7
51. Wu, H.; Wacker, D.; Mileni, M.; Katritch, V.; Han, G. W.; Vardy, E.; Liu, W.; Thompson, A. A.; Huang, X. P.; Carroll, F. I.; Mascarella, S. W.; Westkaemper, R. B.; Mosier, P. D.; Roth, B. L.; Cherezov, V.; Stevens, R. C. Structure of the Human κ-opioid Receptor in Complex with JDTic Nature 2012, 485, 327-332 10.1038/nature10939
52. Chavkin, C.; Sud, S.; Jin, W.; Stewart, J.; Zjawiony, J. K.; Siebert, D. J.; Toth, B. A.; Hufeisen, S. J.; Roth, B. L. Salvinorin A, an Active Component of the Hallucinogenic Sage Salvia Divinorum is a Highly Efficacious Kappa-opioid Receptor Agonist: Structural and Functional Considerations J. Pharmacol. Exp. Ther. 2004, 308, 1197-1203 10.1124/jpet.103.059394
53. Yan, F.; Bikbulatov, R. V.; Mocanu, V.; Dicheva, N.; Parker, C. E.; Wetsel, W. C.; Mosier, P. D.; Westkaemper, R. B.; Allen, J. A.; Zjawiony, J. K.; Roth, B. L. Structure-based Design, Synthesis, Biochemical and Pharmacological Characterization of Novel Salvinorin A Analogues as Active State Probes of the κ-Opioid Receptor Biochemistry 2009, 48, 6898-6908 10.1021/bi900605n
54. Polepally, P. R.; Huben, K.; Vardy, E.; Setola, V.; Mosier, P. D.; Roth, B. L.; Zjawiony, J. K. Michael Acceptor Approach to the Design of New Salvinorin A-based High Affinity Ligands for the Kappa-opioid Receptor Eur. J. Med. Chem. 2014, 85, 818-829 10.1016/j.ejmech.2014.07.077
55. Roth, B. L.; Baner, K.; Westkaemper, R.; Siebert, D.; Rice, K. C.; Steinberg, S.; Ernsberger, P.; Rothman, R. B. Salvinorin A: a Potent Naturally Occurring Nonnitrogenous κ Opioid Selective Agonist Proc. Natl. Acad. Sci. U. S. A. 2002, 99, 11934-11939 10.1073/pnas.182234399
56. Yan, F.; Mosier, P. D.; Westkaemper, R. B.; Stewart, J.; Zjawiony, J. K.; Vortherms, T. A.; Sheffler, D. J.; Roth, B. L. Identification of the Molecular Mechanisms by which the Diterpenoid Salvinorin A Binds to k-opioid Receptors Biochemistry 2005, 44, 8643-8651 10.1021/bi050490d
57. Lamb, K.; Tidgewell, K.; Simpson, D. S.; Bohn, L. M.; Prisinzano, T. E. Antinociceptive Effects of Herkinorin, a MOP Receptor Agonist Derived from Salvinorin A in the Formalin Test in Rats: New Concepts in Mu Opioid Receptor Pharmacology Drug Alcohol Depend. 2012, 121, 181-188 10.1016/j.drugalcdep.2011.10.026
58. Wootten, D.; Christopoulos, A.; Sexton, P. M. Emerging Paradigms in GPCR Allostery: Implications for Drug Discovery Nat. Rev. Drug Discovery 2013, 12, 630-44 10.1038/nrd4052
59. Spetea, M.; Asim, M. F.; Wolber, G.; Schmidhammer, H. The μ Opioid Receptor and Ligands Acting at the μ Opioid Receptor, as Therapeutics and Potential Therapeutics Curr. Pharm. Des. 2013, 19, 7415-7434 10.2174/13816128113199990362
60. Vukojević, V.; Ming, Y.; D'Addario, C.; Hansen, M.; Langel, U.; Schulz, R.; Johansson, B.; Rigler, R.; Terenius, L. Mu-opioid Receptor Activation in Live Cells FASEB J. 2008, 22, 3537-3548 10.1096/fj.08-108894
61. Langelier, B.; Linard, A.; Bordat, C.; Lavialle, M.; Heberden, C. Long Chain-polyunsaturated Fatty Acids Modulate Membrane Phospholipid Composition and Protein Localization in Lipid Rafts of Neural Stem Cell Cultures J. Cell. Biochem. 2010, 110, 1356-1364 10.1002/jcb.22652
62. Mahmood, I.; Liu, X.; Neya, S.; Hoshino, T. Influence of Lipid Composition on the Structural Stability of G-Protein Coupled Receptor Chem. Pharm. Bull. 2013, 61, 426-437 10.1248/cpb.c12-01059
63. Saulière-Nzeh, A. N.; Millot, C.; Corbani, M.; Mazères, S.; Lopez, A.; Salomé, L. Agonist-selective Dynamic Compartmentalization of Human Mu Opioid Receptor as Revealed by Resolutive FRAP Analysis J. Biol. Chem. 2010, 285, 14514-14520 10.1074/jbc.M109.076695
64. Guixà-González, R.; Ramírez-Anguita, J. M.; Kaczor, A. A.; Selent, J. Simulating G Protein-coupled Receptors in Native-like Membranes: From Monomers to Oligomers Methods Cell Biol. 2013, 117, 63-90 10.1016/B978-0-12-408143-7.00004-9
65. Ranganathan, A.; Dror, R. O.; Carlsson, J. Insights into the role of Asp79(2.50) in β2 adrenergic receptor activation from molecular dynamics simulations Biochemistry 2014, 53 (46) 7283-7296 10.1021/bi5008723
66. Granier, S.; Manglik, A.; Kruse, A. C.; Kobilka, T. S.; Thian, F. S.; Weis, W. I.; Kobilka, B. K. Structure of the d-opioid Receptor Bound to Naltrindole Nature 2012, 485, 400-404 10.1038/nature11111
67. Harding, W. W.; Tidgewell, K.; Byrd, N.; Cobb, H.; Dersch, C. M.; Butelman, E. R.; Rothman, R. B.; Prisinzano, T. E. Neoclerodane Diterpenes as a Novel Scaffold for μ Opioid Receptor Ligands J. Med. Chem. 2005, 48, 4765-4771 10.1021/jm048963m
68. Tidgewell, K.; Groer, C. E.; Harding, W. W.; Lozama, A.; Schmidt, M.; Marquam, A.; Hiemstra, J.; Partilla, J. S.; Dersch, C. M.; Rothman, R. B.; Bohn, L. M.; Prisinzano, T. E. Herkinorin Analogues with Differential Beta-arrestin-2 interactions J. Med. Chem. 2008, 51, 2421-2431 10.1021/jm701162g
69. Collu, F.; Ceccarelli, M.; Ruggerone, P. Exploring Binding Properties of Agonists Interacting with a d-Opioid Receptor PLoS One 2012, 7, e52633 10.1371/journal.pone.0052633
70. Riley, A. P.; Groer, C. E.; Young, D.; Ewald, A. W.; Kivell, B. M.; Prisinzano, T. E. Synthesis and κ-Opioid Receptor Activity of Furan-Substituted Salvinorin A Analogues J. Med. Chem. 2014, 57, 10464-10475 10.1021/jm501521d
71. Standfuss, J.; Edwards, P. C.; D'Antona, A.; Fransen, M.; Xie, G.; Oprian, D. D.; Schertler, G. F. X. The Structural Basis of Agonist-induced Activation in Constitutively Active Rhodopsin Nature 2011, 471, 656-660 10.1038/nature09795
72. Li, J.; Edwards, P. C.; Burghammer, M.; Villa, C.; Schertler, G. F. Structure of Bovine Rhodopsin in a Trigonal Crystal Form J. Mol. Biol. 2004, 343, 1409-1438 10.1016/j.jmb.2004.08.090
73. Bailey, C. P.; Couch, D.; Johnson, E.; Griffiths, K.; Kelly, E.; Henderson, G. Mu-opioid Receptor Desensitization in Mature Rat Neurons: Lack of Interaction Between DAMGO and Morphine J. Neurosci. 2003, 23, 10515-10520
74. Saulière-Nzeh, A. N.; Millot, C.; Corbani, M.; Mazères, S.; Lopez, A.; Salomé, L. Agonist-selective Dynamic Compartmentalization of Human Mu Opioid Receptor as Revealed by Resolutive FRAP Analysis J. Biol. Chem. 2010, 285, 14514-14520 10.1074/jbc.M109.076695
75. Xu, H.; Partilla, J. S.; Wang, X.; Rutherford, J. M.; Tidgewell, K.; Prisinzano, T. E.; Bohn, L. M.; Rothman, R. B. A Comparison of Noninternalizing (Herkinorin) and Internalizing (DAMGO) Mu-opioid Agonists on Cellular Markers Related to Opioid Tolerance and Dependence Synapse 2007, 61, 166-175 10.1002/syn.20356